Trial intelligence / Profile preview

Quetiapine vs Haloperidol Cocktail for Agitation in the ER

NCT00457366Phase 4Completed

Sponsor
University of Southern California
Start
May 2006
Primary completion
Aug 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of quetiapine (extended-release tablet, brand name: Bipresso) in agitation, sponsored by University of Southern California. Started May 2006; status: completed.

02

Drugs

quetiapine (extended-release tablet, brand name: Bipresso)
03

Conditions

agitation

Beyond the preview

Go deeper on NCT00457366.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00457366.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call